Research News
Here you'll find all the latest news in PN research. There will be information on work the Foundation is funding plus other industry news. The connections to some of the website may take some time based on the speed of your PC; please be patient as you access the articles.
Chemo Induced Peripheral Neuropathy
Diabetic Peripheral Neuropathy
Chemo-Induced Peripheral Neuropathy:
Diabetic Peripheral Neuropathy:
Jan 2012:
Recently Published Study Investigating Alpha Lipoic for Diabetes Resulted in General Systemic Improvement
Nutri-Med Logic Corp has taken the results of a recent published study, in the European Journal of Nutrition to report on the benefits of R-Alpha Lipoic for Diabetes. This article reports on the study and expands on the benefits of this nutrient.
Source: PRWeb; SFGate.com
HIV Peripheral Neuropathy:
Complementary Therapies
Agent Orange and the VA:
Other PN News:
Jan 2012:
Evolution in the Pain Therapy Drug Market: Nociceptive and Neuropathic Drug Development
With pain affecting 1.5 billion people worldwide, mcuh work is needed to understand pain, what is currently available to treat pain, and what should be developed over the next 5 years. Chronic pain is increasing and is closely associated with aging, cancer, diabetes, and AIDS. A new market research report is available that will provide some of these answers.
Source: PRNewswire
Archived Research Articles
Please Click Here to read research articles from 2011
Please Click Here to read research articles from 2010
Please Click Here to read research articles from 2009
Please Click Here to read research articles from 2008
Interesting Tidbit
Costs of Neuropathic Pain
Results of a review of health care claims indicate the annual excess health care costs associated with peripheral neuropathic pain ranges from $1,600 - $7,000, depending on the specific pain condition.
Source: Journal of Pain, American Pain Society


